Articles by Keyword for

The FDA is requiring that Avodart and Proscar manufacturers disclose that there is an approximately 50% increased incidence of high grade prostate cancer with their usage. It also pointed out that they are not approved for prostate cancer prevention. These drugs block the conversion of testosterone to dihydro-testosterone, which is believed to be one the causes...

  Patients with low risk prostate cancer under active surveillance may benefit from vitamin D3 supplementation at 4000 IU per day according to an article in the Journal of Endocrinology Metabolism. In patients with Gleason 6 prostate cancers, those treated with 4000 IU of vitamin D3 for one year, 55% had a decrease in Gleason findings or fewer positive...